Gujarat Kidney and Super Speciality Fined by BSE and NSE for Delay in Board Intimation
Gujarat Kidney and Super Speciality Limited, formerly known as Gujarat Kidney And Superspeciality Private Limited and previously Vihaan Medicare Private Limited, confirmed receiving fines from both the National Stock Exchange of India Limited (NSE) and BSE Limited. The penalties were imposed for the company's failure to provide prior intimation regarding the meeting of the Board of Directors.The authorities levied the fine on the company after determining a delay in furnishing the necessary pre-meeting notice. The notice of the action was received on April 15, 2026.
The penalty assessed by both the stock exchanges was Rs. 10,000/- (basic fine plus GST). The violation cited by the authorities was the delay in providing prior intimation about the Board of Directors meeting, contravening regulations related to the company's listing requirements.
The financial penalties received from the BSE and NSE are detailed below:
| Authority | Date of Action | Penalty Imposed | Violation |
|---|---|---|---|
| National Stock Exchange of India Limited (NSE) | April 15, 2026 | Rs. 10,000/- (basic fine plus GST) | Delay in furnishing prior intimation about the Board of Directors meeting. |
| BSE Limited | April 15, 2026 | Rs. 10,000/- (basic fine plus GST) | Delay in furnishing prior intimation about the Board of Directors meeting. |
The company stated that the levy of the fines has no impact on the financial, operational, or any other activities of Gujarat Kidney and Super Speciality Limited. The company is responsible for making the required payment of the fine within the timelines prescribed by both stock exchanges.
GKSL Stock Price Movement
Today, Gujarat Kidney And Super Speciality Limited shares edged higher, closing at ₹112.06, representing a 3.41% gain for the session. The upward movement was supported by solid trading activity, with the stock recording a total volume of 651,845 shares.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.